Latest News for PAYD
Zymeworks Inc. acquires Theravance Biopharma for $929M, pivoting to a hybrid biotech and royalty/cash-flow platform anchored by Yupelri. ZYME gains durable, growing cash flows—$60M annually from Yupelri—with patent protection to 2039, supporting internal R&D and reducing reliance on equity issuance. The acquisition's innovative financing structure ringfences risk, offers immediate accretion, and diversifies revenue…
MARLBOROUGH, Mass., May 11, 2026 /PRNewswire/ - Paid Inc. (OTC: PAYD), together with its subsidiary ShipTime Canada Inc., a leading logistics technology platform offering advanced shipping and freight solutions across North America, is pleased to announce the appointment of Lance Healy to its Board of Directors.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PAYD.
U.S. House Trading
No House trades found for PAYD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.